First test of new lupus drug in children shows promise

NCT ID NCT05687526

Completed Disease control Sponsor: RemeGen Co., Ltd. Source: ClinicalTrials.gov ↗

Summary

This early-stage study tested how a drug called telitacicept behaves in the bodies of children with lupus. Sixteen young patients received the drug alongside their standard lupus treatments. Researchers primarily measured drug levels in the blood and also checked for safety and early signs of whether it helped control lupus symptoms.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Chengdu Women's & Children's Central Hospital

Chengdu, Sichuan, China
Children's Hospital of Capital Institute of Pediatrics

Beijing, Beijing Municipality, China
Children's Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China
Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China
Children's Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, China
Henan Children's Hospital

Zhengzhou, Henan, China
Hunan Children's Hospital

Changsha, Hunan, China
Nanjing Children's Hospital

Nanjing, Jiangsu, China
Peking Union Medical College Hospital

Beijing, Beijing Municipality, China
The First Hospital of Jilin University

Changchun, Jilin, China
The Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China
Xi'an Children's Hospital

Xi'an, Shaanxi, China

Conditions

Explore the condition pages connected to this study.

SYSTEMIC LUPUS ERYTHEMATOSUS